Analyst stock forecast
Bolt Biotherapeutics Forecast: $29.00 Analyst Target
Direct answer
Bolt Biotherapeutics's average price target is $29.00.
The target implies +710.1% from the recorded current price, and the consensus rating is none.
The low target implies +39.7%, the high target implies +1,995%, and the range spans 1,955.3% of the current price.
Forecast evidence checked September 27, 2026.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.58
- Average price target
- $29.00
- High price target
- $75.00
- Low price target
- $5.00
- Low target gap
- +39.7%
- Target upside
- +710.1%
- High target gap
- +1,995%
- Target range width
- 1,955.3%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 27, 2026
- Valid through
- October 4, 2026
Explore related company data
Read the frequently asked questions.
What is Bolt Biotherapeutics's average price target?
Bolt Biotherapeutics's verified average price target is $29.00. The target range is $5.00 to $75.00.
How far are Bolt Biotherapeutics's low and high targets from the recorded price?
The low target implies +39.7%, while the high target implies +1,995%.
How many analysts are included in Bolt Biotherapeutics's consensus?
The verified consensus includes 3 analysts.
How is Bolt Biotherapeutics's target upside or downside calculated?
The average target of $29.00 is divided by the recorded price of $3.58, then one is subtracted to produce +710.1%. This does not guarantee a future return.
When was Bolt Biotherapeutics's analyst forecast verified?
The data was verified on 2026-09-27. The dataset is valid through 2026-10-04.